Related Experiment Video
Updated: Sep 4, 2026

The Collective Trust Game: An Online Group Adaptation of the Trust Game Based on the HoneyComb Paradigm
Published on: October 20, 2022
From diligence to verification: The emergence of the TechBio-Investor
1GSK.ai, GSK, London, England, UK; Ethox Centre, University of Oxford, Oxford, England, UK; Uehiro Institute for Practical Ethics, University of Oxford, Oxford, England, UK.
Abstract:
Recent technical advances, including AI co-scientists and agentic systems, increasingly allow TechBios to undertake scientific verification at scale. In addition to facilitating internal discovery efforts, these capabilities can also be used for making external investment decisions. The emerging synergies between discovery and investment enable a new type of hybrid entity, the TechBio-Investor, which has the potential to reshape the economics and ethics of biotech investing. Scaled verification can help improve capital allocation, steering investment toward stronger science and in a sector where most drugs fail, thereby conserving resources. The same capabilities also carry risks, including the uneven distribution of benefits and the conflicts faced by TechBio-Investors that compete with, invest in and bet against rivals.
Related Concept Videos
Equity Theory
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Mechanical Systems
Electro-mechanical Systems
A key component of the DC motor is the armature, a rotating circuit positioned within a magnetic field. As an electric current passes through the...
Mechanical Efficiency of Real Machines
However, in reality, no machine can be truly ideal, and all of them experience some...
Dynamic Equilibrium